Results 201 to 210 of about 409,422 (240)
Some of the next articles are maybe not open access.

Malignant mesotheliomas and chemotherapy

Journal of Surgical Oncology, 1980
AbstractOf 77 patients with mesotheliomas, 63.6% had pleural involvement, 31.2% had peritoneal involvement, and 5.2% had involvement at other sites. The presenting symptoms varied with the location of the primary. Surgery and irradiation did not appear to influence the course of the diffuse type.
C P, Karakousis, M, Seddiq, R, Moore
openaire   +2 more sources

[Malignant pleural mesothelioma].

Minerva chirurgica, 2001
Malignant pleural mesothelioma is a severe disease closely associated with asbestos exposure, at work or environmental. Its incidence has risen for some decades and it's expected to peak between 2010 and 2020. Up today, no treatment has been demonstrated as effective in influencing disease-related survival and the median prognosis ranges between 9 and ...
Rena Ottavio, Oliaro Alberto.
openaire   +5 more sources

Malignant peritoneal mesothelioma

The American Journal of the Medical Sciences, 2023
Malignant peritoneal mesothelioma (MPM) is a rare, life-threatening malignant tumor. We present a report of a rare case of a 67-year-old male patient with MPM and severe abdominal pain, bloating, and bloody ascites as manifestations. The diagnosis was confirmed by cytology of ascites aspiration fluid and further verified by laparoscopic exploratory ...
Cai-Pu, Chun   +8 more
openaire   +2 more sources

Malignant Pleural Mesothelioma

The American Journal of the Medical Sciences, 2005
Malignant pleural mesothelioma is an uncommon tumor; only about 3000 cases are diagnosed annually in the United States. Cases were described early in the 20th century, but their relationship to asbestos exposure was not documented until 1960. Since then, the incidence has appeared to increase, and numerous epidemiologic studies have confirmed that ...
Norman M. Kaplan   +2 more
openaire   +2 more sources

Malignant peritoneal mesothelioma

Current Treatment Options in Oncology, 2001
This paper summarizes the author's thoughts about the use of cytoreductive surgery combined with intraperitoneal hyperthermic chemotherapy (CS-IPHC) for treatment of peritoneal malignant mesothelioma. Pleural malignant mesotheliomas are by far more common (about ten- to thirty-fold) than the peritoneal variants (2.2 cases per 1 million in the US ...
openaire   +2 more sources

Malignant mesothelioma 2008

Current Opinion in Pulmonary Medicine, 2008
Mesothelioma is an aggressive malignancy of the pleura with poor survival. There will be approximately 3000 cases of mesothelioma in the United States annually. Multimodality treatment including neoadjuvant chemotherapy in selected individuals followed by extrapleural pneumonectomy and radiation has been studied in recent trials for its effects on ...
Michael D, Zervos   +2 more
openaire   +2 more sources

Advances in Malignant Mesothelioma

New England Journal of Medicine, 2005
Malignant mesothelioma is an aggressive tumor of serosal surfaces, such as the pleura and the peritoneum. This tumor was once rare, but its incidence is increasing worldwide, probably as a result of widespread exposure to asbestos, a factor with which it is associated.
Bruce W S, Robinson, Richard A, Lake
openaire   +2 more sources

Malignant pleural mesothelioma

American Journal of Health-System Pharmacy, 2012
PURPOSE The etiology, diagnosis, staging, and management of malignant pleural mesothelioma (MPM) are reviewed, with an emphasis on clinical trials of newer approaches to first-line, second-line, and adjuvant chemotherapy.In the past decade, more effective chemotherapy regimens have been developed for patients with MPM, a rapidly progressing disease ...
Sheree E, Chen, Makala B, Pace
openaire   +2 more sources

Localized Malignant Mesothelioma

American Journal of Surgical Pathology, 2005
Localized malignant mesotheliomas are uncommon sharply circumscribed tumors of the serosal membranes with the microscopic appearance of diffuse malignant mesothelioma but without any evidence of diffuse spread. Little is known about their behavior. We report 23 new cases.
Timothy Craig, Allen   +11 more
openaire   +2 more sources

Chemotherapy of Malignant Mesothelioma

Oncology, 2009
Six patients with malignant mesothelioma were treated with various chemo-therapeutic agents. Two of three patients treated with 5-fluorouracil (5-FU) had relatively prolonged complete responses. The possible antitumor effect of 5-FU in malignant mesothelioma should be confirmed by a larger series or collection of cases.
R E, Gerner, G E, Moore
openaire   +2 more sources

Home - About - Disclaimer - Privacy